Oct 4 (Reuters) - Standard BioTools Inc LAB.O :
* STANDARD BIOTOOLS AND SOMALOGIC TO COMBINE IN ALL-STOCK
MERGER
CREATING A DIVERSIFIED LEADER IN LIFE SCIENCES TOOLS
* STANDARD BIOTOOLS INC - GENERATES ESTIMATED $80 MILLION OF
ANNUAL COST SYNERGIES BY 2026 AND ENHANCED COMBINED PATH TO
PROFITABILITY
* STANDARD BIOTOOLS INC - SOMALOGIC REAFFIRMS FULL YEAR 2023
REVENUE GUIDANCE OF $80 - $84 MILLION
* STANDARD BIOTOOLS INC - STANDARD BIOTOOLS INCREASES FULL
YEAR
2023 REVENUE GUIDANCE TO $100 - $105 MILLION
* STANDARD BIOTOOLS - UNDER DEAL,SOMALOGIC SHAREHOLDERS TO
GET
1.11 SHARES OF STANDARD BIOTOOLS COMMON STOCK FOR EACH SHARE OF
SOMALOGIC STOCK OWNED
* STANDARD BIOTOOLS INC - UPON CLOSE OF TRANSACTION,
STANDARD
BIOTOOLS SHAREHOLDERS WILL OWN APPROXIMATELY 43% OF COMBINED
COMPANY
* STANDARD BIOTOOLS INC - UPON CLOSE, COMBINED COMPANY'S
BOARD
WILL CONSIST OF SEVEN DIRECTORS, THREE OF WHOM WILL BE
DESIGNATED BY STANDARD BIOTOOLS
* STANDARD BIOTOOLS INC - UPON CLOSING OF DEAL, SOMALOGIC
SHAREHOLDERS WILL OWN APPROXIMATELY 57% OF COMBINED COMPANY ON A
FULLY DILUTED BASIS
* STANDARD BIOTOOLS INC - UPON CLOSE, MICHAEL EGHOLM WILL
SERVE AS
CHIEF EXECUTIVE OFFICER, JEFF BLACK WILL SERVE AS CHIEF
FINANCIAL OFFICER
* STANDARD BIOTOOLS - COMBINED CO WILL OPERATE UNDER
STANDARD
BIOTOOLS NAME WITH FACILITIES IN CALIFORNIA, COLORADO,
MASSACHUSETTS, CANADA AND SINGAPORE
Source text for Eikon: ID:nGNX2Yr4qg
Further company coverage: LAB.O
((Reuters.Briefs@thomsonreuters.com;))